Jack Summer
Internal Medicine · Washington, DCNPI 1366514820
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 115 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 16.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,726 and has fallen 90.9% since, to $158 in 2021.
Across 115 payments — averaging $18.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$350
- Amgen$303
- Lilly USA, LLC$224
- Novartis$186
- Kowa Pharmaceuticals America, Inc.$165
- Amarin Pharma, Inc.$126
- plus $790 from 18 others
What the payments were for
- Food & beverage$2,145100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 18 | $350 |
| Amgen(2 entities) | 17 | $303 |
| Lilly USA, LLC | 11 | $224 |
| Novartis | 10 | $186 |
| Kowa Pharmaceuticals America, Inc. | 10 | $165 |
| Amarin Pharma, Inc. | 7 | $126 |
| Regeneron Healthcare Solutions, Inc. | 5 | $106 |
| Radius Health, Inc. | 4 | $95 |
| Novo Nordisk | 4 | $70 |
| Bristol Myers Squibb | 3 | $65 |
| E.r. Squibb & Sons, L.L.C. | 3 | $62 |
| GSK | 3 | $57 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $45 |
| AstraZeneca | 2 | $41 |
| Merck | 3 | $39 |
| Johnson & Johnson | 3 | $39 |
| UCB, Inc. | 2 | $38 |
| Mallinckrodt Enterprises LLC | 1 | $26 |
| Biohaven Pharmaceuticals, Inc. | 1 | $23 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| Assertio Therapeutics, Inc. | 1 | $21 |
| Sanofi Pasteur Inc. | 1 | $19 |
| Pfizer | 1 | $13 |
| Arbor Pharmaceuticals, Inc. | 1 | $12 |
How this compares
$2,145 in reported general payments places this provider in the 85th percentile of 645 internal medicine providers in District of Columbia.
See all internal medicine providers in District of Columbia →
Other internal medicine in Washington
- Andrea SingerWashington$850K
- Kathryn SowerwineWashington$831K
- Douglas WardWashington$233K
- Geoffrey GibneyWashington$185K
- Kevin GriffithsWashington$180K
- Bruce RashbaumWashington$86K
- Jessica Wang-MemoliWashington$56K
- Dana McGintyWashington$47K
- Geeta NayyarWashington$46K
- Marie BorumWashington$42K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.